A different kind of radiation therapy can help cancer patients preserve who they are. About half of all cancer patients ...
AI is transforming oncology by improving early detection, diagnosis, and treatment personalization through advanced data ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...
The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human ...
A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...
RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies, today announced continued commercial momentum with a growing ...
From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 highlight patient care advances.
Peptinovo Biopharma, an Ann Arbor-based biotechnology company pioneering targeted cancer therapies through its first-of-its-kind proprietary PALM™ nanotechnology, today announced it has received ...
To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors ...
A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...
Rebecca Siegel highlights alarming cancer disparities among American Indian, Alaska Native, and Black populations, ...
Brazilian researchers have identified previously unknown forms of a protein linked to breast cancer. The discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback